Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management - Summary - MDSpire

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management

  • By

  • Qi Jian

  • Naueen A. Chaudhry

  • Fanxing Du

  • Ellen Zimmermann

  • Tianze Jiao

  • April 29, 2026

  • 0 min

Share

Objective:

To examine the association between the use of immunomodulators or biologics therapies and the risk of major adverse cardiovascular events (MACE) among older adults with inflammatory bowel disease (IBD).

Key Findings:
  • Add a statement linking findings to potential changes in clinical practice.
Interpretation:

Emphasize cautious application of findings in clinical settings.

Limitations:
  • Include examples of potential confounding factors.
Conclusion:

Strengthen the call for urgent further research.

Original Source(s)

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management

  • by Qi Jian, Naueen A. Chaudhry, Fanxing Du, Ellen Zimmermann, Tianze Jiao

  • April 29, 2026

Related Content

The role of the complement system in gastrointestinal-related diseases

Poststroke anxiety and depression: epidemiology, mechanisms, and management strategies

Boosting hemianopia recovery: the power of interareal cross-frequency brain stimulation